Skip links
Orsini a specialty pharmacy partner for YORVIPATH® (palopegteriparatide), for hypoparathyroidism. Learn more →
Orsini now distributing BridgeBio's ATTRUBY™ (acoramidis), for ATTR-CM. Learn more →
Prescribe a Therapy
Orsini
Resources

Orsini Resources

  • All
  • Blog Posts
  • In the News
  • Videos
  • White Papers

Orsini chosen by Ascendis to distribute treatment for rare endocrine disorder in the U.S.

Orsini Chosen by BridgeBio as a Specialty Pharmacy Provider for ATTRUBY™ (acoramidis), for the Treatment of Cardiomyopathy of Transthyretin-Mediated Amyloidosis

Orsini Now Distributing CASGEVY® (exagamglogene autotemcel), a Gene-Editing Therapy

Orsini Now a Specialty Pharmacy Provider for SAJAZIR™ (icatibant) Injection, to Treat Acute HAE Attacks

Orsini Is Now a Specialty Pharmacy Provider for FUROSCIX® (furosemide injection), an Infused Diuretic for Congestive Heart Failure

Orsini Launches ORBIT™ (Orsini Rare Business Intelligence Technology) to Enhance Rare Disease Patient Care

Orsini Chosen as the Exclusive Specialty Pharmacy Provider for MIPLYFFA™ (arimoclomol), the First FDA-Approved Treatment for Niemann-Pick Disease Type C

[Video] Rare Disease Patient Management

Specialty Pharmacy Continuum: Specialty Pharmacies’ Role in Gene Therapy

Orsini Now Dispensing Livdelzi (seladelpar), for Treatment of Rare Liver Disease

Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders

[Video] Gene Therapy Patient Case Management

Specialty Pharmacy Continuum: Gene Therapy a Hot Trend in Cold Chain

Orsini Announcement: Orsini Specialty Pharmacy Chosen to Dispense YARGESA (miglustat)

White Paper: Optimizing Patient Care in Rare Hematologic Conditions: Novel Therapies in Classical Hematology and the Role of Specialty Pharmacy in Driving Enhanced Outcomes

Orsini Announcement: Orsini Specialty Pharmacy Welcomes Two Executive Leadership Hires

Orsini selected as the exclusive specialty pharmacy for WAINUA (eplontersen) for adults with hereditary transthyretin-mediated amyloid polyneuropathy

Orsini Specialty Pharmacy Selected as Distribution Partner for Adzynma (ADAMTS13, recombinant-krhn), a Newly Approved Treatment for an Ultra-Rare Blood Clotting Disorder

Orsini Specialty Pharmacy Partners with Amicus Therapeutics to Dispense New Therapy for the Treatment of Late-Onset Pompe Disease

Orsini Specialty Pharmacy Names Darin DeCarlo Chief Growth Officer

Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for VEOPOZ™ (pozelimab-bbfg), the First and Only Treatment for CHAPLE Disease

Orsini Selected by BioMarin to Dispense ROCTAVIAN™, the First Gene Therapy for the Treatment of Severe Hemophilia A

Orsini selected as the exclusive specialty pharmacy for WAINUA (eplontersen) for adults with hereditary transthyretin-mediated amyloid polyneuropathy

Optimizing Patient Care Services with Rare Disease Limited Distribution Drugs

Now In Stock: ADZYNMA (ADAMTS13, recombinant-krhn), for patients with cTTP

Orsini Specialty Pharmacy Selected as Distribution Partner for Adzynma (ADAMTS13, recombinant-krhn), a Newly Approved Treatment for an Ultra-Rare Blood Clotting Disorder

Orsini Specialty Pharmacy Partners with Amicus Therapeutics to Dispense New Therapy for the Treatment of Late-Onset Pompe Disease

The Burden of Prior Authorizations: How Specialty Pharmacies Can Help

Importance of Hand Hygiene in Healthcare: Handwashing Awareness Week

Choosing a Specialty Pharmacy to Support ERT Therapies

Demystifying Four Common Pain Points for Patients Living with Rare Diseases

5 Ways COVID-19 Impacts Immunocompromised & Rare Disease Patients

3 Opportunities for Patients with Rare & Complex Diseases in the Time of COVID-19

Choosing a Specialty Pharmacy to Support Hereditary ATTR Amyloidosis Patients

7 Facts About Rare Diseases to Raise Awareness on Rare Disease Day

Six Reasons the Specialty Pharmacist Role is Increasingly Important

What Makes Orsini Special? Meet Our Specialty Pharmacists

Choosing a Specialty Pharmacy to Support Idiopathic Pulmonary Fibrosis Patients

Six Ways to Help Patients Manage Rare Diseases

Six Ways the Right Specialty Pharmacy Partner Helps Improve Medication Adherence

Five Ways to Define and Redefine Rare Diseases

What is a Specialty Pharmacy?

Medical Benefits Billing for Specialty Therapies

Orsini Specialty Pharmacy Selected as a Limited Distribution Partner for AMVUTTRA™ (vutrisiran)

Orsini Specialty Pharmacy Selected by Marinus Pharmaceuticals as the Exclusive Specialty Pharmacy Partner for ZTALMY®

Choosing a Specialty Pharmacy to Support Pompe Disease Patients

7 Helpful Facts to Raise Awareness for Duchenne Muscular Dystrophy (DMD)

Choosing a Specialty Pharmacy to Support Patients with X-linked hypophosphatemia

Six Ways Orsini Ensures No Patient is Left Behind

Orsini Salutes Healthcare Quality Week

Choosing a Specialty Pharmacy to Support Mucopolysaccharidosis (MPS) Patients

Orsini Specialty Pharmacy Selected by Provention Bio as a Limited Distribution Partner for TZIELD

Choosing a Specialty Pharmacy to Support Tardive Dyskinesia Patients

Payor Considerations When Evaluating a Specialty Pharmacy Partner

From Diagnosis to Treatment: The Difficulties Rare Disease Patients Encounter

Orsini Specialty Pharmacy Earns Rare Disease Pharmacy Center of Excellence Designation from URAC

Rare Disease Day: A Reminder of Our Immense Responsibility to Serve Patients and Families

Rare Disease Day: In Loving Memory of Tommy

The 3 Distribution Models to Choose for a Specialty Drug Launch

Why You Need a Limited Distribution Network for Rare Disease Drugs

The Importance of Payor Credentialing When Selecting a Specialty Pharmacy Partner

Orsini Specialty Pharmacy Selected as part of the Limited Specialty Pharmacy Network For VYJUVEK™

Operational Challenges Payors Face with Rare Disease Limited Distribution Drugs

Choosing a Specialty Pharmacy to Support Patients with Recurrent Pericarditis

Orsini Specialty Pharmacy Now Dispensing VOWST™ (fecal microbiota spores, live – brpk)

Orsini Selected by Sarepta Therapeutics to Dispense ELEVIDYS (delandistrogene moxeparvovec-rokl), the First Gene Therapy to Treat Duchenne Muscular Dystrophy

7 Factors Payors Should Consider When Choosing a Specialty Pharmacy Partner

Orsini Specialty Pharmacy Selected by Glaukos® Corporation as a Specialty Distribution Partner for Photrexa® and Photrexa® Viscous

[eBook] Living with Duchenne Muscular Dystrophy (DMD): Tommy’s Story

Choosing a Specialty Pharmacy to Support Spinal Muscular Atrophy

Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for Evkeeza™

Rare Disease Day: Raising Awareness for Patients Living with Rare Diseases

[Video] The Value of a Specialty Pharmacy Partner for Manufacturers

Orsini Specialty Pharmacy Selected by Sarepta Therapeutics as a Limited Distribution Partner for AMONDYS 45 (casimersen)

How to Manage the Administrative Burden of Prior Authorization

[eBook] Living with Spinal Muscular Atrophy: Sienna & Wesley’s Stories

Orsini Specialty Pharmacy Selected by PTC Therapeutics as a Limited Distribution Partner for EMFLAZA® (deflazacort)

5 Services Providers Should Expect from a Specialty Pharmacy

Choosing a Specialty Pharmacy to Support Duchenne Muscular Dystrophy

Importance of the ACHC Distinction in Rare Diseases and Orphan Drugs for a Specialty Pharmacy Partner

Orsini Specialty Pharmacy Selected by Alnylam® Pharmaceuticals as Limited Distribution Partner for OXLUMO™

Choosing a Specialty Pharmacy to Support Hereditary Angioedema

Orsini Specialty Pharmacy Selected by Glaukos® Corporation as a Specialty Distribution Partner for Photrexa® and Photrexa® Viscous

[eBook] Living with Duchenne Muscular Dystrophy (DMD): Tommy’s Story

Choosing a Specialty Pharmacy to Support Spinal Muscular Atrophy

Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for Evkeeza™

Rare Disease Day: Raising Awareness for Patients Living with Rare Diseases

[Video] The Value of a Specialty Pharmacy Partner for Manufacturers

How to Manage the Administrative Burden of Prior Authorization

[Video] How a Specialty Pharmacy Can Make All the Difference for Patients

3 Proven Ways to Help Patients Manage the Costs of Specialty Medications for Rare Conditions

[Patient Story] Living with Hereditary ATTR amyloidosis: Dennis’ Story

Gene Therapy Guides Future Treatment for Rare Diseases

COVID-19 Lengthens the Journey to Health Equity for Rare Disease Patients

8 Facts to Know About Mucopolysaccharidosis on MPS Awareness Day

6 Important Facts to Know About Hereditary Angioedema

Patients Share Their Journeys Living with Rare & Complex Diseases

Clinical & Operational Services to Consider When Selecting a Specialty Pharmacy Partner

Pharmaceutical Manufacturer & Payor Expectations When Partnering with a Specialty Pharmacy

6 Facts About Alzheimer’s Disease

Communication & Collaboration Between a Pharmaceutical Manufacturer and Specialty Pharmacy

Orsini Specialty Pharmacy Selected to Dispense Aduhelm™ for the Treatment of Alzheimer’s Disease

Orsini Specialty Pharmacy Offers Patients Access to Generic Treatment for Severe Homozygous Cystinuria

Dietary Guidelines: Gaucher Disease Type 1 Patients Taking Miglustat

7 Common Characteristics of a Specialty Drug

Tackling the Challenge of Health Literacy, One Word at a Time

Living with Duchenne Muscular Dystrophy: Tommy’s Poem

7 Facts to Know About DMD on World Duchenne Awareness Day

Three Reasons Why Newborn Screening Awareness Month is More Important than Ever

Orsini Specialty Pharmacy Selected By Sanofi As A Limited Distribution Partner For Nexviazyme®

6 Metrics to Track Specialty Pharmacy Patient Satisfaction

7 Ways to Support Caregivers During National Family Caregivers Month

[Video] Rare Disease Day: What’s Your Why